本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Axsome Therapeutics, Inc.

204.07
-12.5100-5.78%
盤後206.001.93+0.95%19:51 EDT
成交量:59.13萬
成交額:1.23億
市值:106.89億
市盈率:-54.15
高:215.02
開:215.02
低:203.78
收:216.58
52周最高:260.19
52周最低:112.90
股本:5,238.08萬
流通股本:4,383.14萬
量比:0.90
換手率:1.35%
股息:- -
股息率:- -
每股收益(TTM):-3.7685
每股收益(LYR):-3.6821
淨資產收益率:-245.10%
總資產收益率:-16.31%
市淨率:128.32
市盈率(LYR):-55.42

資料載入中...

2026/09/03

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/10

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/08/05

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/07/28

超過5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/07/15

重要事件披露

Form 8-K - Current report
2026/07/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

重要事件披露

Form 8-K - Current report
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/03

重要事件披露

Form 8-K - Current report
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2026/06/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities